Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1431, 2004-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ciprofloxacin ER value for money in uncomplicated UTIs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 449, 2004-01 ,pp. :
Access to resources
Recommend
Extended-release ciprofloxacin a more convenient option for UTIs
Inpharma, Vol. 1, Iss. 1366, 2002-01 ,pp. :
Amantadine `value for money' for influenza in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 367, 2002-01 ,pp. :
Bevacizumab "best value for money" in MCRC . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 666, 2012-01 ,pp. :